Korb, C.A.; Gerstenberger, E.; Lorenz, K.; Bell, K.; Beck, A.; Scheller, Y.; Beutgen, V.M.; Wolters, D.; Grus, F.H.
Correlation of Functional and Structural Outcomes with Serum Antibody Profiles in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial. J. Clin. Med. 2024, 13, 7033.
https://doi.org/10.3390/jcm13237033
AMA Style
Korb CA, Gerstenberger E, Lorenz K, Bell K, Beck A, Scheller Y, Beutgen VM, Wolters D, Grus FH.
Correlation of Functional and Structural Outcomes with Serum Antibody Profiles in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial. Journal of Clinical Medicine. 2024; 13(23):7033.
https://doi.org/10.3390/jcm13237033
Chicago/Turabian Style
Korb, Christina A., Eva Gerstenberger, Katrin Lorenz, Katharina Bell, Anna Beck, Yvonne Scheller, Vanessa M. Beutgen, Dominik Wolters, and Franz H. Grus.
2024. "Correlation of Functional and Structural Outcomes with Serum Antibody Profiles in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial" Journal of Clinical Medicine 13, no. 23: 7033.
https://doi.org/10.3390/jcm13237033
APA Style
Korb, C. A., Gerstenberger, E., Lorenz, K., Bell, K., Beck, A., Scheller, Y., Beutgen, V. M., Wolters, D., & Grus, F. H.
(2024). Correlation of Functional and Structural Outcomes with Serum Antibody Profiles in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial. Journal of Clinical Medicine, 13(23), 7033.
https://doi.org/10.3390/jcm13237033
